Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

[摘要]

[发布日期] [发布机构]

[效力级别] [学科分类] 肿瘤学

[关键词] Chronic myeloid leukemia;Targeted therapy;Imatinib;Dasatinib;Nilotinib [时效性]

浏览次数：10